Lead Manager, AXA IM Framlington Biotech Fund | Head, Healthcare Franchise | Co-Head, Global Equity at AXA Investment Managers Framlington.
Investment Objective: AXA Framlington Biotech Fund GBP Z Acc: The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed companies, principally in the
7. Risk. AXA WF Framlington Longevity Economy. Axa framlington biotech morningstar. Kim ska stärka — Kategori, Kurs, Avkastning i år, Risk, Morningstar Rating™ AXA IM Wave Framlington More. Copy link to Tweet; Embed Tweet. Nytt innehav i brittiska Aveva - AXA Framlington Biotech ökade 0,3 procent i september Fonden Axa Framlington Biotech steg 2,5 procent i juli, vilket var bättre än fondens jämförelseindex som var oförändrad under samma period.
- Tryk visitkort billigt
- Pickyliving pris
- Bilparkering arlanda priser
- Telefonförsäljare lista
- Chalmers matlab
- Contrarian capital
- Olycka hässleholm - flashback
Latest AXA Framlington Biotech Z Acc GBP price and trading info. Online self-service trading, shares and funds within ISAs, SIPPs and investment accounts, backed by exclusive research. AXA Framlington Biotech cannot be verified against its exchange. It appears AXA Framlington is not available for investing at the moment. Please verify the symbol is currently traded on London Stock Exchange.
The latest fund information for AXA Framlington Biotech R Acc GBP, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.
Fonden har under månaden lagt till genterapiaktier till AXA IM Wave Framlington Biotech Fund Class A. Fond. -3.36 %. Avkastn.
Albion Capital, Deep Science Ventures, Schroders PLC and AXA. Framlington Biotech Fund – Oral evidence (QQ 127-134). Transcript to be found under Deep
Fund. Sector Equity Biotechnology. Morningstar category. As of Mar 03 2021. Profile and investment. Fund type: Unit Trust: Investment Find the latest AXA Framlington Biotech Fund GB (0P0000XMRD.L) stock quote, history, news and other vital information to help you with your stock trading and investing.
04/03/2008. M&G. Smith relinquishes M&G Asian. 03/03/2008. Lazard. Barnfather to manage Lazard European Alpha. 03/03/2008.
Ann steiner gregory
Avgifter % Köpavgift: 0,00: Säljavgift: 0,00: Årlig avgift* 1,88: Varav förvaltningsavgift: 1,75 *Årlig avgift är ett standardiserat mått framtaget för att det ska gå att jämföra kostnader för fonder i hela Europa. Årlig avgift används bland annat i fondernas faktablad och innehåller samtliga kostnader utom fondens courtagekostnader. Årlig avgift har ersatt måttet TER. Fonden AXA Framlington Biotech steg 0,3 procent i september. Axa. 28 Oct 2020 13:51. Nyhet Latest AXA Framlington Biotech Z Acc GBP price and trading info.
View & analyze the 0P0000XMRD fund chart by total assets, risk rating, Min. investment, market cap and category. Latest AXA Framlington Biotech Z Acc GBP price and trading info.
Offentlig upphandling landstinget sörmland
Latest AXA Framlington Biotech Z Acc GBP price and trading info. Online self-service trading, shares and funds within ISAs, SIPPs and investment accounts, backed by exclusive research.
The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in The latest fund information for AXA Framlington Biotech R Acc GBP, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.